FGFRL1 affects chemoresistance of small‐cell lung cancer by modulating the PI3K/Akt pathway via ENO1

Fibroblast growth factor receptor‐like 1 (FGFRL1), a member of the FGFR family, has been demonstrated to play important roles in various cancers. However, the role of FGFRL1 in small‐cell lung cancer (SCLC) remains unclear. Our study aimed to investigate the role of FGFRL1 in chemoresistance of SCLC...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:J Cell Mol Med
Prif Awduron: Chen, Rui, Li, Deyu, Zheng, Meng, Chen, Bin, Wei, Ting, Wang, Yu, Li, Man, Huang, Weimei, Tong, Qin, Wang, Qi, Zhu, Yaru, Fang, Wei, Guo, Linlang, Fang, Shun
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: John Wiley and Sons Inc. 2020
Pynciau:
Original Articles
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC7011138/
https://ncbi.nlm.nih.gov/pubmed/31957179
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jcmm.14763
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg